Technology
Health
Pharmaceutical

Biohaven Pharmaceutical

1,246

$35.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.53 (-1.48%) Today
$0.00 (0.00%) As of 6:00 PM EDT after-hours

Why Robinhood?

You can buy or sell BHVN and other stocks, options, ETFs, and crypto commission-free!

About BHVN

Biohaven Pharmaceutical Holding Company Ltd., also called Biohaven Pharmaceutical, is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. Read More The company was founded in September 2013 and is headquartered in New Haven, CT.

CEO
Vlad Coric
Employees
647
Headquarters
New Haven, Connecticut
Founded
2013
Market Cap
1.95B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.10M
High Today
$36.24
Low Today
$34.05
Open Price
$35.17
Volume
592.77K
52 Week High
$67.86
52 Week Low
$26.56

Collections

Technology
Health
Pharmaceutical
Medical
Biopharmaceutical
Research And Development
2017 IPO
US

BHVN News

ReutersMar 23

BRIEF-Biohaven Pharmaceutical Says If This Planned Vazegepant Phase 3 Trial Is Positive, Would Have Potential Of Filing An NDA Next Year

March 23 (Reuters) - Biohaven Pharmaceutical Holding Company Ltd: * BIOHAVEN PHARMACEUTICAL HOLDING COMPANY - IF THIS PLANNED VAZEGEPANT PHASE 3 TRIAL IS POSIT
72

BHVN Earnings

-$2.85
-$1.90
-$0.95
$0.00
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 5, Pre-Market

People Also Bought

Viking Therapeutics

49,748

$4.75

-1.86%

Viking Therapeutics

49,748

$4.75

-1.86%

Aimmune Therapeutics

4,012

$13.98

-3.19%

Hexo

176,976

$1.06

+1.92%

Amarin

17,314

$13.08

-4.53%

You May Also Like

ASOMY
CAR
DLA
IPO
TMST
USLM
VRRM
BCDAW
MANT
AYTU
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy BHVN

Market Price$35.28
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell BHVN stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up